Skip to content

Nature Avenue: what changed

What changed

Nature Avenue

BE 0773.994.276
NACE 46.460, Wholesale of pharmaceutical and medical goods
filed annual accounts (NBB)
Financial years compared with
Net result for the year
-€321
2024 · -€11,853+€11,532
Equity
€75,292
2024 · €75,613-€321
Cash
€8,667
2024 · €4,031+€4,636
Balance sheet total
€105,922
2024 · €107,893-€1,971

Largest movements

2024 to 2025
Assets
  • Deferred charges and accrued income -€10,000

    no longer reported in 2025 (was €10,000)

  • Receivables within one year +€8,468

    up €8,468 (+10.9%), from €77,737 to €86,205

    of which Trade receivables: +€8,235

  • Stocks and contracts -€5,075

    down €5,075 (-31.5%), from €16,125 to €11,050

  • Cash +€4,636

    up €4,636 (+115%), from €4,031 to €8,667

    mainly Deferred charges and accrued income (+€10,000) and Stocks and contracts (+€5,075)

Equity and liabilities
  • Other debts -€2,000

    down €2,000 (-18.1%), from €11,021 to €9,021

Income statement
  • Gross operating margin +€12,785

    up €12,785, from -€9,993 to €2,793

  • Write-downs +€2,250

    new in 2025: €2,250

  • Staff costs -€861

    no longer reported in 2025 (was €861)

  • Other operating charges -€116

    down €116 (-13.0%), from €890 to €774

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 -€11,853
Gross operating margin +€12,785
Staff costs +€861
Write-downs -€2,250
Other operating charges +€116
Financial income +€1
Financial charges +€19
Result 2025 -€321
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€4,636
Investment €0
Financing €0
Cash 2024 €4,031
Net result for the year -€321
Stocks and contracts +€5,075
Receivables within one year -€8,468
Deferred charges and accrued income +€10,000
Trade debts +€1,054
Tax, wage and social debts -€705
Other debts -€2,000
Cash 2025 €8,667
brings cash intakes cash out
Every line side by side 33 lines
Line Code 2024 2025 Change %
Total assets 20/58 €107,893 €105,922 -€1,971 -1.8%
Current assets 29/58 €107,893 €105,922 -€1,971 -1.8%
Stocks and contracts in progress 3 €16,125 €11,050 -€5,075 -31.5%
Stocks 30/36 €16,125 €11,050 -€5,075 -31.5%
Amounts receivable within one year 40/41 €77,737 €86,205 +€8,468 +10.9%
Trade receivables 40 €61,881 €70,116 +€8,235 +13.3%
Other amounts receivable 41 €15,857 €16,089 +€232 +1.5%
Cash at bank and in hand 54/58 €4,031 €8,667 +€4,636 +115%
Deferred charges and accrued income 490/1 €10,000 - -€10,000
Total equity and liabilities 10/49 €107,893 €105,922 -€1,971 -1.8%
Equity 10/15 €75,613 €75,292 -€321 -0.4%
Contributions 10/11 €64,000 €64,000 = 0.0%
Profit (loss) carried forward 14 €11,613 €11,292 -€321 -2.8%
Amounts payable 17/49 €32,281 €30,630 -€1,651 -5.1%
Amounts payable within one year 42/48 €32,281 €30,630 -€1,651 -5.1%
Trade debts 44 €18,489 €19,543 +€1,054 +5.7%
Suppliers 440/4 €18,489 €19,543 +€1,054 +5.7%
Taxes, remuneration and social security 45 €2,770 €2,066 -€705 -25.4%
Taxes 450/3 €1,500 €566 -€934 -62.3%
Remuneration and social security 454/9 €1,270 €1,500 +€230 +18.1%
Other amounts payable 47/48 €11,021 €9,021 -€2,000 -18.1%
Remuneration, social security and pensions 62 €861 - -€861
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 - €2,250 +€2,250
Other operating charges 640/8 €890 €774 -€116 -13.0%
Gross operating margin 9900 -€9,993 €2,793 +€12,785
Operating profit (loss) 9901 -€11,744 -€232 +€11,512 +98.0%
Financial income 75/76B - €1 +€1
Recurring financial income 75 - €1 +€1
Financial charges 65/66B €109 €90 -€19 -17.1%
Recurring financial charges 65 €109 €90 -€19 -17.1%
Profit (loss) for the period before taxes 9903 -€11,853 -€321 +€11,532 +97.3%
Profit (loss) for the period 9904 -€11,853 -€321 +€11,532 +97.3%
Profit (loss) for the period to be appropriated 9905 -€11,853 -€321 +€11,532 +97.3%
Calculation and sources

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 8 November 2026 via checked.be.